- Gene therapy edges towards commercial reality The tale of two biotech companies suggests a tricky road ahead.
- Clean living could cut one third of common cancers Healthier living could prevent about one third of the most common cancers in rich countries
- Anti-nausea drug may combat opiate addiction in people addicted to morphine, oxycodone, and other opiate drugs
- Fertility Treatments Unlikely to Raise Ovarian Cancer Risk women taking fertility drugs in order to become pregnant have not had definitive evidence that such ...
- Depression risk increased among cancer patients People who have been diagnosed with cancer are at greater risk of being hospitalized with depression
- Cold's "family tree" may lead to cure: study Researchers who mapped the DNA of more than 100 different cold viruses
- Aspirin reduces risk of colon polyps recurring For people with a history of colorectal polyps or cancer, taking aspirin is an effective way to redu...
- A Smoker is More Likely To Quit Smoking If There Are Pets A large number of pet owners who smoke would consider trying to quit for the health of their beloved...
- Multivitamins may not thwart cancer, heart disease Millions of people take a multivitamin in the hopes of averting disease, but the supplements
- Gene therapy promising for rheumatoid arthritis Researchers have successfully used gene therapy to substantially reduce joint pain in two patients w...
2/23/2009
NEW YORK (Reuters Health) - People who have been diagnosed with cancer are at greater risk of being hospitalized with depression, new research from Denmark shows.
While the risk was greatest in the year following a person's diagnosis, the likelihood of being hospitalized for depression among survivors of certain types of cancer remained high for several years, Dr. Susanne O. Dalton of the Danish Cancer Society in Copenhagen and her colleagues found.
There's some evidence that cancer patients are more likely to be depressed than people in the general population, the researchers note. Estimates of depression prevalence among these patients range from 0 percent to 38 percent.
Despite this variability, which is likely due to differences in how depression is diagnosed and the type of cancer patients have, as well as how advanced their disease is and whether or not they are hospitalized, "depression has typically been underdiagnosed and undertreated in the oncology setting," Dalton and her team write in the Journal of Clinical Oncology.
To better understand the short- and long-term depression risk of cancer patients, the researchers looked at 608,591 Danish men and women who were diagnosed with cancer and were followed for up to 31 years. The average follow-up after diagnosis was 4.2 years.
Within the first year of being diagnosed with cancer, the researchers found, men and women with cancer were about twice as likely to be hospitalized for depression as were men and women in the general population. Over the next decade, the relative risk of hospitalization for depression was increased 21 percent for men and 5 percent for women.
Depression risk varied by cancer type. For both sexes, the risk remained high for up to 10 years after being diagnosed with a hormone-related cancer, such as breast cancer or prostate cancer. The risk also stayed high for a decade among women with smoking-related cancers and men with virus- and immune-related cancers.
In the first year after diagnosis, increased risk ranged from 1.16-fold for women with colorectal cancer to 3.08-fold for men with brain cancer.
Given that more and more people are living longer after being diagnosed with cancer, the researchers note, taking care of cancer survivors with depression will be increasingly important. "Early recognition and effective treatment of depression, both in the cancer setting and beyond, would have the potential to prevent admission for depression and thus reduce patient suffering and enhance the quality of life for cancer survivors," they conclude.
For more cancer news and information: www.yourcancertoday.com

© Reuters 2006. All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world.